Get the free weekly contract digest
The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
New new contracts, summarized for you
No login, no app to check — it comes to you
See who's moving and how much in your market
Pan Cancer T secures €4.25 Million in Seed Extension Round with InnovationQuarter as New Investor
Contract Type
partnership
RotterdamBiotechnologyHealth CareDescription
Pan Cancer T, a pioneering biotech start-up, has successfully closed a €4.25 million Seed Extension round with a new investor InnovationQuarter and continued support from existing investors, bringing the total funding to approximately €11 million. This funding will allow the company to advance its lead product toward the clinic, offering new hope for patients with triple negative breast cancer, and to seek business development partnerships with Biotech and Pharma collaborators.